标题
Dopamine Agonists for Pituitary Adenomas
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-08-21
DOI
10.3389/fendo.2018.00469
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists
- (2016) Y Greenman et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Cabergoline for Cushing’s disease: a large retrospective multicenter study
- (2016) A Ferriere et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Cabergoline treatment for recurrent Cushing’s disease during pregnancy
- (2016) Afif Nakhleh et al. Hormones-International Journal of Endocrinology and Metabolism
- Cabergoline in acromegaly
- (2016) Emmanuelle Kuhn et al. Pituitary
- Management of clinically non-functioning pituitary adenoma
- (2015) Philippe Chanson et al. ANNALES D ENDOCRINOLOGIE
- Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas andin vivoresponse to cabergoline therapy
- (2015) Leonardo Vieira Neto et al. CLINICAL ENDOCRINOLOGY
- The Treatment of Cushing's Disease
- (2015) Rosario Pivonello et al. ENDOCRINE REVIEWS
- Cabergoline Use for Pituitary Tumors and Valvular Disorders
- (2015) Renata S. Auriemma et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients
- (2015) P. Burman et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Treatment Outcome Results from the Bulgarian Acromegaly Database: Adjuvant Dopamine Agonist Therapy is Efficient in Less than One Fifth of Non-irradiated Patients
- (2015) S. Vandeva et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapy
- (2014) Youwei Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists
- (2013) Trevor A. Howlett et al. CLINICAL ENDOCRINOLOGY
- Preoperative Normalization of Cortisol Levels in Cushing's Disease After Medical Treatment: Consequences for Somatostatin and Dopamine Receptor Subtype Expression and In Vitro Response to Somatostatin Analogs and Dopamine Agonists
- (2013) R. van der Pas et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine
- (2013) Qiang Li et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Cabergoline Therapy for Cushing Disease Throughout Pregnancy
- (2013) Irene Woo et al. OBSTETRICS AND GYNECOLOGY
- Combination therapy for Cushing’s disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?
- (2013) M. Barbot et al. Pituitary
- Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial
- (2012) C. E. Higham et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Short-term treatment with cabergoline can lead to tumor shrinkage in patients with nonfunctioning pituitary adenomas
- (2012) Erica C. Garcia et al. Pituitary
- Pegvisomant and cabergoline combination therapy in acromegaly
- (2012) I. Bernabeu et al. Pituitary
- The role of somatostatin and dopamine D2 receptors in endocrine tumors
- (2011) Federico Gatto et al. ENDOCRINE-RELATED CANCER
- Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
- (2011) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Place of Cabergoline in Acromegaly: A Meta-Analysis
- (2011) Laure Sandret et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline
- (2011) Pamela U. Freda et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression of dopamine 2 receptor subtype mRNA in clinically nonfunctioning pituitary adenomas
- (2011) Zhipeng Su et al. NEUROLOGICAL SCIENCES
- Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas
- (2011) Filip Gabalec et al. Pituitary
- Efficacy of Cabergoline in Uncured (Persistent or Recurrent) Cushing Disease After Pituitary Surgical Treatment with or without Radiotherapy
- (2010) Anurag Lila et al. Endocrine Practice
- Cabergoline monotherapy in the long-term treatment of Cushing's disease
- (2010) Ariane Godbout et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Immunohistochemical detection of dopamine D2 receptors in human pituitary adenomas.
- (2010) Marek Pawlikowski FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment
- (2010) J. Roemmler et al. GROWTH HORMONE & IGF RESEARCH
- Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior
- (2010) Zhe Bao Wu et al. JOURNAL OF NEURO-ONCOLOGY
- Differential Expression of Somatostatin and Dopamine Receptor Subtype Genes in Adrenocorticotropin (ACTH)-secreting Pituitary Tumors and Silent Corticotroph Adenomas
- (2009) Toru TATENO et al. ENDOCRINE JOURNAL
- Effect of injectable bromocriptine in patients with Cushing's disease
- (2009) C. Invitti et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas
- (2009) Christiaan de Bruin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly
- (2009) Leonardo Vieira Neto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The clinical–molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology
- (2009) Diego Ferone et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing’s disease
- (2009) Lucio Vilar et al. Pituitary
- Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study
- (2008) T. Florio et al. ENDOCRINE-RELATED CANCER
- Medical therapy for clinically non-functioning pituitary adenomas
- (2008) A. Colao et al. ENDOCRINE-RELATED CANCER
- Expression and Functional Analysis of Dopamine Receptor Subtype 2 and Somatostatin Receptor Subtypes in Canine Cushing’s Disease
- (2008) C. de Bruin et al. ENDOCRINOLOGY
- Correlation ofin Vitroandin VivoSomatotropic Adenoma Responsiveness to Somatostatin Analogs and Dopamine Agonists with Immunohistochemical Evaluation of Somatostatin and Dopamine Receptors and Electron Microscopy
- (2008) Diego Ferone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement
- (2008) B. M. K. Biller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
- (2008) Rosario Pivonello et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas
- (2007) A. Saveanu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started